Structural and molecular basis of carbohydrate-protein interaction systems as potential therapeutic targets

Current Pharmaceutical Design

Volumn 17, Issue 17, 2011, Pages 1672-1684

  Kamiya, Yukiko ^a,b   Yagi Utsumi, Maho ^a,b   Yagi, Hirokazu ^b   Kato, Koichi ^a,b,c,d  

^a OKAZAKI INSTITUTE FOR INTEGRATIVE BIOSCIENCE   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c OCHANOMIZU UNIVERSITY   (Japan)

^d GLYENCE Co Ltd   (Japan)

Author keywords

Amyloid ; Carbohydrate protein interaction; Frontal affinity chromatography; Ganglioside; Hemagglutinin; Lectin; NMR spectroscopy; X ray crystallography

Indexed keywords

AMYLOID BETA PROTEIN; CARBOHYDRATE; CONCANAVALIN A; GANGLIOSIDE; GANGLIOSIDE GM1; LECTIN; PROTEIN;

ALZHEIMER DISEASE; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; CARBOHYDRATE ANALYSIS; CHEMICAL STRUCTURE; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; DEGENERATIVE DISEASE; DRUG STRUCTURE; DRUG TARGETING; HUMAN; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN FUNCTION; PROTEIN STRUCTURE; VIRUS INFECTION;

ANIMALS; CARBOHYDRATES; HUMANS; MODELS, THEORETICAL; PROTEINS;

EID: 79960324099     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211796355074     Document Type: Article

References (122)

1. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1999; 1473: 4-8.
2. Darling R. J, Kuchibhotla U, Glaesner W, et al. Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions. Biochemistry 2002; 41: 14524-14531.
3. Su D, Zhao H, Xia H. Glycosylation-modified erythropoietin with improved half-life and biological activity. Int J Hematol 2010; 91: 238-244.
4. Yamaguchi Y, Nishimura M, Nagano M, et al. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim Biophys Acta 2006; 1760: 693-700.
5. Mimura Y, Church S, Ghirlando R, et al. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol 2000; 37: 697-706.
6. Yamaguchi Y, Takahashi N, Kato K. eds. Molecular interactions: Antibody structures. In: Kamerling JP, Ed. Comprehensive Glycoscience. Oxford: Elsevier 2007 pp. 745-763.
7. Shinkawa T, Nakamura K, Yamane N, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003; 278: 3466-3473.
8. Niwa R, Hatanaka S, Shoji-Hosaka E, et al. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcγRIIIa functional polymorphism. Clin Cancer Res 2004; 10: 6248-6255.
9. Shibata-Koyama M, Iida S, Okazaki A, et al. The N-linked oligosaccharide at FcγRIIIa Asn-45: an inhibitory element for high FcγRIIIa binding affinity to IgG glycoforms lacking core fucosylation. Glycobiology 2009; 19: 126-134.
10. Matsumiya S, Yamaguchi Y, Saito J, et al. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol 2007; 368: 767-779.
11. Kato K, Kamiya Y. Structural views of glycoprotein-fate determination in cells. Glycobiology 2007; 17: 1031-1044.
12. Aebi M, Bernasconi R, Clerc S, Molinari M. N-glycan structures: recognition and processing in the ER. Trends Biochem Sci 2010; 35: 74-82.
13. Takeda Y, Totani K, Matsuo I, Ito Y. Chemical approaches toward understanding glycan-mediated protein quality control. Curr Opin Chem Biol 2009; 13: 582-591.
14. Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 2003; 4: 181-191.
15. Kamiya Y, Kamiya D, Urade R, Suzuki T, Kato K. Sophisticated Modes of Sugar Recognition by Intracellular Lectins Involved in Quality Control of Glycoproteins, In: G. Powell; O. McCabe, Eds. Glycobiology Research Trends. N.Y: Nova Scirnce Publisher, Inc 2009; pp. 27-40.
16. Kamiya Y, Kato K. Sugar recognition by intracellular lectins that determine the fates of glycoproteins. Trends in Glycosci. Glycotech 2006; 18: 231-244.
17. Uchimura K, Gauguet JM, Singer MS, et al. A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol 2005; 6: 1105-1113.
18. van Zante A, Rosen SD. Sulphated endothelial ligands for L-selectin in lymphocyte homing and inflammation. Biochem Soc Trans 2003; 31: 313-317.
19. Suzuki Y. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 2005; 28: 399-408.
20. Zhang B, Cunningham MA, Nichols WC, et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat. Genet 2003; 34: 220-225.
21. Nichols W. C, Seligsohn U, Zivelin A, et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 1998; 93: 61-70.
22. Yuki N. Carbohydrate mimicry: a new paradigm of autoimmune diseases. Curr Opin Immunol 2005; 17: 577-582.
23. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligo-saccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA 2004; 101: 11404-11409.
24. Gorbenko GP, Kinnunen PKJ. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem Phys Lipids 2006; 141: 72-82.
25. Yanagisawa K. Role of gangliosides in Alzheimer's disease. Biochim Biophys Acta 2007; 1768: 1943-1951.
26. Ariga T, McDonald MP, Yu RK. Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease-a review. J Lipid Res 2008; 49: 1157-1175.
27. Matsuzaki K, Kato K, Yanagisawa K. Aβpolymerization through interaction with membrane gangliosides. Biochim Biophys Acta 2010; 1801: 868-877.
28. von Itzstein M. Disease-associated carbohydrate-recognising proteins and structure-based inhibitor design. Curr Opin Struct Biol 2008; 18: 558-566.
29. Yamaguchi Y. Development and applocations of stable-isotope-labelling methods oriented to structural glycobiology. Trends in Glycosci. Glycotech 2008; 20: 117-130.
30. Blixt O, Head S, Mondala T, et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci USA 2004; 101: 17033-17038.
31. Seeberger PH, Haase WC. Solid-phase oligosaccharide synthesis and combinatorial carbohydrate libraries. Chem Rev 2000; 100: 4349-4394.
32. Matsuo I, Ito Y. Synthesis of an octamannosyled glycan chain, the key oligosaccharide structure in ER-associated degradation. Carbohydr Res 2003; 338: 2163-2168.
33. Morelle W, Michalski JC. Analysis of protein glycosylation by mass spectrometry. Nat Protoc 2007; 2: 1585-1602.
34. Kato K, Takahashi N. GALAXY database and pyridilaminated oligosaccharide library. In Taniguchi N, Suzuki A, Narimatsu H, Kawasaki T, Hase S, Eds. Experimental Glycoscience: Glycobiology. The Netherlands: Springer 2008; pp. 413-416.
35. Takahashi N, Kurimoto E, Yamaguchi Y, Kato K. [Multi-dimensional HPLC method in glycomics]. Tanpakushitsu Kakusan Koso 2003; 48: 1412-1418.
36. Takahashi N, Kato K. GALAXY (Glycoanalysis by the Three Axes of MS and Chromatography): a web application that assists structural analyses of N-glycans. Trends. Glycosci. Glycotech 2003; 14: 235-251.
37. Kato K, Sasakawa H, Kamiya Y, et al. 920 MHz ultra-high field NMR approaches to structural glycobiology. Biochim Biophys Acta 2008; 1780: 619-625.
38. Kato K, Yamaguchi Y, Arata Y. Stable-isotope-assisted NMR approaches to glycoproteins using immunoglobulin G as a model system. Prog Nucl Magn Reson Spectrosc 2010; 56: 346-359.
39. Yagi H, Kato K. Multidimentional HPLC mapping method for the structural analysis of anionic N-glycans. Trends Glycosci Glycotech 2009; 21: 95-104.
40. Sharon N, Lis H. Lectins, London: Springer-Verlag 2006.
41. http://www.cermav.cnrs.fr/lectines/.
42. Jeyaprakash AA, Geetha Rani P, Banuprakash Reddy G, et al. Crystal structure of the jacalin-T-antigen complex and a comparative study of lectin-T-antigen complexes. J Mol Biol 2002; 321: 637-645.
43. May AP, Robinson RC, Vinson M, Crocker PR, Jones EY. Crystal structure of the N-terminal domain of sialoadhesin in complex with 3' sialyllactose at 1.85 Å resolution. Mol Cell 1998; 1: 719-728.
44. Wimmerova M, Mitchell E, Sanchez JF, Gautier C, Imberty A. Crystal structure of fungal lectin: six-bladed β-propeller fold and novel fucose recognition mode for Aleuria aurantia lectin. J Biol Chem 2003; 278: 27059-27067.
45. Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunol Rev 1998; 163: 19-34.
46. Ng KK, Kolatkar AR, Park-Snyder S, et al. Orientation of bound ligands in mannose-binding proteins. Implications for multivalent ligand recognition. J Biol Chem 2002; 277: 16088-16095.
47. Kogelberg H, Feizi T. New structural insights into lectin-type proteins of the immune system. Curr Opin Struct Biol 2001; 11: 635-643.
48. Yamaguchi Y, Kato K. [Structural biology of sugar recognition by lectins]. Seikagaku 2004; 76: 269-277.
49. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000; 69: 531-569.
50. Wiley DC, Skehel JJ. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 1987; 56: 365-394.
51. Xu D, Newhouse EI, Amaro RE, et al. Distinct glycan topology for avian and human sialopentasaccharide receptor analogues upon binding different hemagglutinins: a molecular dynamics perspective. J Mol Biol 2009; 387: 465-491.
52. Gamblin SJ, Haire LF, Russell RJ, et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 2004; 303: 1838-1842.
53. Naeve CW, Hinshaw VS, Webster RG. Mutations in the hemagglutinin receptor-binding site can change the biological properties of an influenza virus. J Virol 1984; 51: 567-569.
54. Connor RJ, Kawaoka Y, Webster RG, Paulson JC. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994; 205: 17-23.
55. Guo CT, Takahashi N, Yagi H, et al. The quail and chicken intestine have sialyl-galactose sugar chains responsible for the binding of influenza A viruses to human type receptors. Glycobiology 2007; 17: 713-724.
56. Thongratsakul S, Songserm T, Poolkhet C, et al. Determination of N-linked sialyl-sugar chains in the lung of domestic cats and dogs in Thailand susceptible to the highly pathogenic avian influenza virus (H5N1). Open Glycoscience 2009; 2: 28-36.
57. Sriwilaijaroen N, Kondo S, Yagi H, et al. Analysis of N-glycans in embryonated chicken egg chorioallantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses. Glycoconj J 2009; 26: 433-443.
58. Takemae N, Ruttanapumma R, Parchariyanon S, et al. Alterations in receptor-binding properties of swine influenza viruses of the H1 subtype after isolation in embryonated chicken eggs. J Gen Virol; 91: 938-948.
59. Gambaryan AS, Boravleva EY, Matrosovich TY, et al. Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus. Antiviral Res 2005; 68: 116-123.
60. Hidari KI, Murata T, Yoshida K, et al. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection. Glycobiology 2008; 18: 779-788.
61. Totani K, Kubota T, Kuroda T, et al. Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses. Glycobiology 2003; 13: 315-326.
62. Moothoo DN, Canan B, Field R. A, Naismith JH. Man α1-2 Man α-OMe-concanavalin A complex reveals a balance of forces involved in carbohydrate recognition. Glycobiology 1999; 9: 539-545.
63. Wang WC, Cummings RD. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked α-2, 3 to penultimate galactose residues. J Biol Chem 1988; 263: 4576-4585.
64. Knibbs RN, Goldstein IJ, Ratcliffe RM, Shibuya N. Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins. J Biol Chem 1991; 266: 83-88.
65. Imberty A, Gautier C, Lescar J, et al. An unusual carbohydrate binding site revealed by the structures of two Maackia amurensis lectins complexed with sialic acid-containing oligosaccharides. J Biol Chem 2000; 275: 17541-17548.
66. Fiedler K, Simons K. A putative novel class of animal lectins in the secretory pathway homologous to leguminous lectins. Cell 1994; 77: 625-626.
67. Nufer O, Mitrovic S, Hauri HP. Profile-based data base scanning for animal L-type lectins and characterization of VIPL, a novel VIP36-like endoplasmic reticulum protein. J. Biol. Chem 2003; 278: 15886-15896.
68. Füllekrug J, Scheiffele P, Simons K. VIP36 localisation to the early secretory pathway. J Cell Sci 1999; 112 (Pt 17): 2813-2821.
69. Velloso LM, Svensson K, Schneider G, Pettersson RF, Lindqvist Y. Crystal structure of the carbohydrate recognition domain of p58/ERGIC-53, a protein involved in glycoprotein export from the endoplasmic reticulum. J. Biol. Chem 2002; 277: 15979-15984.
70. Velloso LM, Svensson K, Pettersson RF, Lindqvist Y. The crystal structure of the carbohydrate-recognition domain of the glyco-protein sorting receptor p58/ERGIC-53 reveals an unpredicted metal-binding site and conformational changes associated with calcium ion binding. J. Mol. Biol 2003; 334: 845-851.
71. Satoh T, Cowieson NP, Hakamata W, et al. Structural basis for recognition of high mannose type glycoproteins by mammalian transport lectin VIP36. J. Biol. Chem 2007; 282: 28246-28255.
72. Lahtinen U, Svensson K, Pettersson R. F. Mapping of structural determinants for the oligomerization of p58, a lectin-like protein of the intermediate compartment and cis-Golgi. Eur J Biochem 1999; 260: 392-397.
73. Appenzeller C, Andersson H, Kappeler F, Hauri HP. The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat. Cell Biol 1999; 1: 330-334.
74. Nufer O, Guldbrandsen S, Degen M, et al. Role of cytoplasmic C-terminal amino acids of membrane proteins in ER export. J Cell Sci 2002; 115: 619-628.
75. Hauri HP, Appenzeller C, Kuhn F, Nufer O. Lectins and traffic in the secretory pathway. FEBS Lett 2000; 476: 32-37.
76. Nyfeler B, Kamiya Y, Boehlen F, et al. Deletion of 3 residues from the C-terminus of MCFD2 affects binding to ERGIC-53 and causes combined factor V and factor VIII deficiency. Blood 2008; 111: 1299-1301.
77. Zhang B, Kaufman RJ, Ginsburg D. LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J. Biol. Chem 2005; 280: 25881-25886.
78. Kamiya Y, Kamiya D, Yamamoto K, et al. Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36. J. Biol. Chem 2008; 283: 1857-1861.
79. Kamiya Y, Yamaguchi Y, Takahashi N, et al. Sugar-binding properties of VIP36, an intracellular animal lectin operating as a cargo receptor. J. Biol. Chem 2005; 280: 37178-37182.
80. Kasai K, Oda Y, Nishikawa M, Ishii S. Frontal affinity chromatoraphy: theory for its application to studies on specofoc interactions of biomolecules. J. Chromatogr 1986; 376: 33-47.
81. D'Alessio C, Caramelo JJ, Parodi AJ. UDP-GlC:glycoprotein glucosyltransferase-glucosidase II, the ying-yang of the ER quality control. Semin Cell Dev Biol 2010; 21: 491-499.
82. Weisz O. A. Acidification and protein traffic. Int Rev Cytol 2003; 226: 259-319.
83. Appenzeller-Herzog C, Roche AC, Nufer O, Hauri HP. pH-induced conversion of the transport lectin ERGIC-53 triggers glycoprotein release. J. Biol. Chem 2004; 279: 12943-12950.
84. Hosokawa N, Kamiya Y, Kato K. The role of MRH domain-containing lectins in ERAD. Glycobiology 2010; 20: 651-660.
85. Williams DB. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J Cell Sci 2006; 119: 615-623.
86. Kawasaki N, Ichikawa Y, Matsuo I, et al. The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. Blood 2008; 111: 1972-1979.
87. Cortini M, Sitia R. ERp44 and ERGIC-53 synergize in coupling efficiency and fidelity of IgM polymerization and secretion. Traffic 2010; 11: 651-659.
88. Anelli T, Ceppi S, Bergamelli L, et al. Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis. Embo J 2007; 26: 4177-4188.
89. Nishio M, Kamiya Y, Mizushima T, et al. Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency. Proc Natl Acad Sci USA 2010; 107: 4034-4039.
90. Guy JE WE, Svärd M, Härd T, and Lindqvist Y. New insights into multiple coagulation factor deficiency from the solution structure of human MCFD2. J. Mol. Biol 2008; 381: 941-955.
91. Zhang B. Recent developments in the understanding of the combined deficiency of FV and FVIII. Br J Haematol 2009; 145: 15-23.
92. Hakomori S. Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization. Glycoconj J 2004; 21: 125-137.
93. Lopez PH, Schnaar RL. Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol 2009; 19: 549-557.
94. Hölmgren J, Lönnroth I, Månsson J, Svennerholm L. Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc Natl Acad Sci USA 1975; 72: 2520-2524.
95. Neu U, Woellner K, Gauglitz G, Stehle T. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc Natl Acad Sci USA 2008; 105: 5219-5224.
96. Kopitz J, von Reitzenstein C, Burchert M, Cantz M, Gabius H. J. Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J Biol Chem 1998; 273: 11205-11211.
97. Merritt EA, Kuhn P, Sarfaty S, et al. The 1.25 Å resolution refinement of the cholera toxin B-pentamer: evidence of peptide backbone strain at the receptor-binding site. J Mol Biol 1998; 282: 1043-1059.
98. Acquotti D, Poppe L, Dabrowski J, et al. Three-dimensional structure of the oligosaccharide chain of GM1 ganglioside revealed by a distance-mapping procedure: a rotating and laboratory frame nuclear overhauser enhancement investigation of native glycolipid in dimethyl sulfoxide and in water-dodecylphosphocholine solutions. J Am Chem Soc 1990; 112: 7772-7778.
99. Brocca P, Berthault P, Sonnino S. Conformation of the oligosaccharide chain of GM1 ganglioside in a carbohydrate-enriched surface. Biophys J 1998; 74: 309-318.
100. Sillerud LO, Yu RK, Schafer DE. Assignment of the carbon-13 nuclear magnetic resonance spectra of gangliosides GM4, GM3, GM2, GM1, GD1a, GD1b, and GT1b. Biochemistry 1982; 21: 1260-1271.
101. 1H-NMR assignments of GM1-oligosaccharide in deuterated water at 500 MHz by two-dimensional spin-echo J-correlated spectroscopy. Arch Biochem Biophys 1986; 245: 157-166.
102. Yagi-Utsumi M, Kameda T, Yamaguchi Y, Kato K. NMR characterization of the interactions between lyso-GM1 aqueous micelles and amyloid β. FEBS Lett 2010; 584: 831-836.
103. Yanagisawa K, Odaka A, Suzuki N, Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): A possible form of preamyloid in Alzheimer's disease. Nat Med 1995; 1: 1062-1066.
104. Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK. Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 1997; 272: 22987-22990.
105. Kakio A, Nishimoto S, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 2002; 41: 7385-7390.
106. Yanagisawa K, McLaurin J, Michikawa M, Chakrabartty A, Ihara Y. Amyloid β-protein (Aβ) associated with lipid molecules: immunoreactivity distinct from that of soluble A. FEBS Lett 1997; 420: 43-46.
107. Hayashi H, Kimura N, Yamaguchi H, et al. A seed for Alzheimer amyloid in the brain. J. Neurosci 2004; 24: 4894-4902.
108. Brocca P, Bernardi A, Raimondi L, Sonnino S. Modeling ganglioside headgroups by conformational analysis and molecular dynamics. Glycoconj J 2000; 17: 283-299.
109. Acquotti D, Fronza G, Ragg E, Sonnino S. Three dimensional structure of GD1b and GD1b-monolactone gangliosides in dimethylsulphoxide: a nuclear Overhauser effect investigation supported by molecular dynamics calculations. Chem Phys Lipids 1991; 59: 107-125.
110. Scarsdale JN, Prestegard JH, Yu RK. NMR and computational studies of interactions between remote residues in gangliosides. Biochemistry 1990; 29: 9843-9855.
111. Ariga T, Kobayashi K, Hasegawa A, et al. Characterization of high-affinity binding between gangliosides and amyloid β-protein. Arch Biochem Biophys 2001; 388: 225-230.
112. Utsumi M, Yamaguchi Y, Sasakawa H, et al. Up-and-down topological mode of amyloid _-peptide lying on hydrophilic/ hydrophobic interface of ganglioside clusters. Glycoconjugate J 2009; 26: 999-1006.
113. Nerelius C, Sandegren A, Sargsyan H, et al. α-helix targeting reduces amyloid-βpeptide toxicity. Proc Natl Acad Sci USA 2009; 106: 9191-9196.
114. Shi J, Yang T, Kataoka S, et al. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. J Am Chem Soc 2007; 129: 5954-5961.
115. Kaida K, Kusunoki S. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review. J Neuroimmunol 2010; 223: 5-12.
116. Yagi-Utsumi M, Matsuo K, Yanagisawa K, Gekko K, Kato K. Spectroscopic Characterization of Intermolecular Interaction of Amyloid β Promoted on GM1 Micelles. International Journal of Alzheimer's Disease 2011; 2011: Article ID 925073, 8 pages doi:10.4061/2011/925073.
117. Kakio A, Nishimoto SI, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem 2001; 276: 24985-24990.
118. Mizuno T, Nakata M, Naiki H, et al. Cholesterol-dependent generation of a seeding amyloid β-protein in cell culture. J Biol Chem 1999; 274: 15110-15114.
119. Di Pasquale E, Fantini J, Chahinian H, et al. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of α-synuclein is corrected by GM3 but not by GM1 gangliosides. J Mol Biol 2010; 397: 202-218.
120. Bucior I, Burger MM. Carbohydrate-carbohydrate interactions in cell recognition. Curr Opin Struct Biol 2004; 14: 631-637.
121. Fadda E, Woods RJ. Molecular simulations of carbohydrates and protein-carbohydrate interactions: motivation, issues and prospects. Drug Discov Today 2010; 15: 596-609.
122. Kamiya Y, Kato K. Structural basis for trafficking and quality control of glycoproteins by intracellular lectins. Tanpakushitsu Kakusan Koso 2008; 53: 1662-1669.